Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Foam vs gauze: which C-Section dressing heals scars better?

NCT ID NCT07482202

Symptom relief Sponsor: Yewon Jung Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compared two types of wound dressings—polyurethane foam and regular gauze—after cesarean delivery. 200 women were randomly assigned to one dressing type, and their scar appearance and infection rates were tracked for 6 months. The goal is to see if the foam dressing leads to better-looking scars and fewer infections.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Polyurethane foam dressing (Mepilex Border Flex)
What this could lead to
If foam dressings prove better, they could become a standard option to improve scar healing and satisfaction after C-sections.
What could go wrong
This is a small, single-surgeon study with 200 Korean women, so results may not apply to all populations. The difference between dressings may be small or not clinically meaningful.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

200 people

The number who actually took part.

Started

May 2024

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 1\. Korean women aged 18 years or older who provided written informed consent to participate in the study 2\. Patients who underwent emergency or elective cesarean section 3\. Patients with a transverse skin and uterine incision (Pfannenstiel incision) 4\. Patients who received prophylactic antibiotics (Cefazolin 1g) intravenously 30 minutes prior to surgery 5\. Patients who completed at least three follow-up visits after discharge Exclusion Criteria: * Patients under 18 years of age 2\. Patients who did not undergo transverse skin or uterine incision (i.e., vertical incision) 3\. Use of antibiotics prior to delivery (excluding prophylactic antibiotics administered at delivery) 4\. Patients taking immunosuppressive drugs 5\. History of adhesive allergy or allergic skin diseases 6\. Patients unable to complete the required follow-up schedule 7\. Patients who did not consent or were unable to understand the study protocol

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cesarian scar are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Surgical Wound Infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cesarian scar Surgical site infection (SSI)

Contacts and locations

Locations

  • Sejong Chungnam National University Hospital

    Sejong, Sejong-si, 30099, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.